Cognoa’s AI platform for autism diagnosis gets first FDA stamp
February 21, 2018 at 09:00 AM EST
Cognoa has gained regulatory recognition for its machine learning software as a class II diagnostic medical device for autism — meaning the digital health startup is now positioned to submit an application for full FDA clearance. Read More